The effects of most commonly prescribed second generation antidepressants on driving ability: A systematic review: 70th Birthday Prof. Riederer

Journal of Neural Transmission

Volumn 120, Issue 1, 2013, Pages 225-232

  Brunnauer, Alexander ^a,b   Laux, Gerd ^a,b  

^a Inn Salzach Klinikum   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antidepressants; Depression; Driving performance

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MAPROTILINE; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; REBOXETINE; SERTRALINE; TRIMIPRAMINE; VENLAFAXINE; VILOXAZINE;

DEPRESSION; DRIVING ABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AUTOMOBILE DRIVING; DATABASES, FACTUAL; HUMANS; PSYCHOMOTOR PERFORMANCE;

EID: 84872287644     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0833-8     Document Type: Review

References (33)

1. Amado Boccara I, Gougoulis N, Poirier-Littre MF, Galinowski A, Loo H (1995) Effects of antidepressants on cognitive functions. Neurosci Biobehav Rev 19:479-493
2. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, Mc Devitt DG, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331-1336 (Pubitemid 28510912)
3. Beblo T, Sinnamon G, Baune BT (2011) Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors. Neuropsychol Rev 21:337-359
4. Bramness JG, Skurtveit S, Neutel CI, Moerland J, Engeland A (2008) Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway. J Clin Psychiatry 69:1099-1103 (Pubitemid 352031593)
5. Brunnauer A, Laux G (2003) Fahrtüchtigkeit und antidepressiva. Psychiat Prax 30(Suppl 2):102-105
6. Brunnauer A, Laux G (2010) Klinisch-Neuropsychologische Aspekte der Therapie mit Psychopharmaka. In: Lautenbacher S, Gauggel S (eds) Neuropsychologie psychischer Störungen. Springer, Berlin, pp 525-549
7. Brunnauer A, Laux G, Geiger E, Soyka M, Möller HJ (2006) Antidepressants and driving ability: results from a clinical study. J Clin Psychiatry 67:1776-1781 (Pubitemid 44955160)
8. Brunnauer A, Laux G, Zwick S, David I, Schmauss M, Messer T, Hermisson I, Möller HJ, Steinberg R, Frommberger U (2008a) Mobility behaviour of patients with mental illness. Dtsch Z Nervenheilkd 27:120-121
9. Brunnauer A, Laux G, David I, Fric M, Hermisson I, Möller HJ (2008b) The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. J Clin Psychiatry 69:1880-1886
10. Grabe HJ, Wolf T, Grätz S, Laux G (1998) The influence of polypharmacological antidepressant treatment on central nervous information processing of depressed patients: implications for fitness to drive. Neuropsychobiology 37:200-204 (Pubitemid 28256880)
11. Herberg KW (1994) Antidepressiva und Verkehrssicherheit. Fortschr Neurol Psychiat 62 (Sonderheft 1):24-28
12. Herberg KW (2001) Verkehrs- und Alltagssicherheit bei Medikation mit Citalopram. Psychopharmakatherapie 8:81-88
13. Hindmarch I (1997) Three antidepressants (amitriptyline, dothiepin, fluoxetine), with and without alcohol, compared with placebo on tests of psychomotor ability related to car driving. Hum Psychopharmacol 2:177-183
14. Hindmarch I, Harrison C (1988) The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving. Hum Psychopharmacol 3:3-20
15. Iwamoto K, Takahashi M, Nakamura Y, Kawamura Y, Ishihara R, Uchiyama Y, Ebe K, Noda A, Noda Y, Yoshida K, Iidaka T, Ozaki N (2008) The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial. Hum Psychopharmacol Clin Exp 23:399-407
16. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994) Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5:591-598 (Pubitemid 24336510)
17. Linnoila M, Stapleton JM, George DT, Lane E, Eckardt MJ (1993) Effects of fluvoxamine, alone and in combination withe ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers. J Clin Psychopharamcol 13:175-180 (Pubitemid 23194738)
18. Mattila M, Sarialho-Kere U, Mattila M (1988) Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy subjects over 50 years of age. J Clin Psychiatry 49(Suppl 8):52-58
19. Mura P, Kintz P, Ludes B, Gaulier JM, Marquet P, Martin-Dupomt S, Vincent F, Kaddour A, Goullé JP, Nouveau J, Moulsma M, Tilhet-Coartet, Pourrat O (2003) Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int 133:79-85
20. O'Hanlon JF, Robbe HWJ, Vermeeren A, van Leuwen C, Danjou PE (1998) Venlafaxine′s effects on healthy volunteers′ driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 18:212-221 (Pubitemid 28266887)
21. Ramaekers JG (2003) Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 64:20-29 (Pubitemid 36182225)
22. Ramaekers JG, Muntjewerf ND, O'Hanlon JFO (1995) A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 39:397-404
23. Ramaekers JG, Ansseau M, Muntjewerff ND, Sweens JP, O'Hanlon JF (1997) Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients. Int Clin Psychopharmacol 12:159-169 (Pubitemid 27283325)
24. Ramaekers JG, Muntjewerf ND, Van Veggel MA, Uiterwijk MMC, O'Hanlon JF (1998) Effects of nocturnal doses of mirtazapine and mianserin on sleep and on daytime psychomotor and driving performance in young, healthy volunteers. Hum Psychopharmacol Clin Exp 13:87-97
25. Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136:873-883
26. Ridout F, Meadows R, Johnsen S, Hindmarch I (2003) A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance. Hum Psychopharmacol Clin Exp 18:261-269 (Pubitemid 36722311)
27. Robbe HWJ, O'Hanlon JFO (1995) Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Psychopharmacol 5:35-42
28. Shen J, Moller HJ, Wang X, Chung SA, Shapiro GK, Li X, Shapiro CM (2009) Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. J Clin Psychiatry 70:370-377
29. Stein RA, Strickland TI (1998) A review of the neuropsychological effects of commonly used prescription medications. Arch Clin Neuropsychol 13:259-284 (Pubitemid 28176427)
30. Vaa T (2003) Impairments diseases, age and their relative risks of accident involvement: results from a metaanalysis. Deliverable R1.1 from EU-project IMMORTAL; TØI report 690. Oslo, Norway; Institute of Transport Economics; 1-48. http://www.immortal.or.at/deliverables phpR1.1. Accessed 21 Aug 2008
31. Wilson SJ, Bailey JE, Alford C, Weinstein A, Nutt DJ (2002) Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood. J Psychopharmacol 16:321-331 (Pubitemid 35470576)
32. Wingen M, Bothmer J, Langer S, Ramaekers JG (2005) Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J Clin Psychiatry 66:436-443 (Pubitemid 40593571)
33. Wingen M, Ramaekers JG, Schmitt JAJ (2006) Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology 188:84-91 (Pubitemid 44268244)